GOLD 2011 pharmacologic management of COPD based on combined assessment... | Download Scientific Diagram
Results for Combo | GrepMed
Table 1 from Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar
Different inhaled corticosteroid doses in triple therapy for chronic obstructive pulmonary disease: systematic review and Bayesian network meta-analysis | Scientific Reports
Evidence Summary - Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma - NCBI Bookshelf
American College of Chest Physicians - In a real-world setting, LAMA-LABA- ICS is as effective as LAMA-LABA to prevent COPD exacerbations, but incidence of pneumonia increased with triple therapy initiation: https://hubs.ly/H0pPLQ20 | Facebook
Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation framework | Respiratory Research | Full Text
Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar
Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation framework | Respiratory Research | Full Text
Asthma - Treatment Options - Google Drawings
COPD Inhalers - Easy to Use Reference Tool - CommPharm Consulting
Smart LABA/ICS combination inhaler launched with automatic usage monitoring | MIMS online
Variability of COPD Inhaler Coverage in Medicare Part D
Frontiers | Single Inhaler LABA/LAMA for COPD
Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis | Respiratory Research | Full Text
Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database | Advances in Therapy
Adding a LAMA to ICS/LABA Therapy: A Meta-analysis of Triple Combination Therapy in COPD - ScienceDirect
LABA/LAMA FDC or LABA/ICS FDC in patients with COPD | COPD
Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box | European Respiratory Society
Available iCS plus LABA combination products | Download Table
JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
LABA/LAMA fixed-dose combinations in patients with COPD: a systematic | COPD
Pharmaceuticals | Free Full-Text | Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABA
Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine
Henna KD on X: "Inhaled steroids have been linked to increased pneumonia esp. n the elderly. We are moving towards LAMA+LABA combination inhalers for COPD. https://t.co/rJsiKkPnUU" / X
